Cancer epitope prediction tools and analysis pipelines in CEDAR
Open Access
- 12 May 2026
- journal article
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (W1) , W13-W21
Abstract
Accurate identification of immunogenic cancer epitopes remains a central challenge in immuno-oncology. The Cancer Epitope Database and Analysis Resource (CEDAR, https://cedar.iedb.org/) was developed to provide comprehensive curation of experimentally validated epitopes and to foster the development of computational tools tailored to the cancer context. Recently, we released a suite of cancer-specific tools and analysis pipelines as part of the https://nextgen-tools.iedb.org/ platform, enabling users to generate, evaluate, and prioritize candidate T cell epitopes in a modular framework. Here, we present the design and functionality of these tools, describe their core methodologies, provide guidance for their use, and illustrate how they can be integrated into end-to-end pipelines. We highlight applications in cancer immunology and personalized immunotherapy by presenting practical use cases.Keywords
All Related Versions
Funding Information
- National Institutes of Health
- National Cancer Institute (U24CA248138)
This publication has 61 references indexed in Scilit:
- Using the Cancer Epitope Database and Analysis Resource (CEDAR)2025
- IEDB and CEDAR: Two Sibling Databases to Serve the Global Scientific Community2023
- Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionCell, 2020
- Evolutionary Pressure against MHC Class II Binding Cancer MutationsCell, 2018
- MHC-I Genotype Restricts the Oncogenic Mutational LandscapeCell, 2017
- MuPeXI: prediction of neo-epitopes from tumor sequencing dataCancer Immunology, Immunotherapy, 2017
- Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypesImmunogenetics, 2011
- NetCTLpan: pan-specific MHC class I pathway epitope predictionsImmunogenetics, 2010
- An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictionsEuropean Journal of Immunology, 2005
- Tumor Antigens2002